© 1995 British Society for Rheumatology
The iatrogenic cost of non-steroidal anti-inflammatory drug therapy
Centre de Recherche en Gestion de I'ecole Polytechnique, l rue Descartes 75005 Paris, France
| Abstract |
|---|
The secondary gastrointestinal effects associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) are well documented in the medical literature. Less addressed is the iatrogenic cost due to the treatment of these secondary effects. Epidemiologic and clinical studies report that the cost of NSAIDs is multiplied by a coefficient that ranges from 1.45 to 3, if the cost of treating the induced gastrointestinal complications is considered. A simple methodology incorporating the direct medical cost of treating complications has been developed to calculate a shadow price of an NSAID, thus reflecting the real cost to the payer of NSAID therapy. The model has been used to compare three NSAIDs on the basis of their relative prices and gastroduodenal toxicity.
KEY WORDS: Non-steroidal anti-inflammatory drugs, Adverse effects, Gastrointestinal, Cost, Iatrogenic, Misoprostol